Authors: WONG SL DRAJESK J CHANG MS WITT G AWNI WM

Citation: Sl. Wong et al., DOSE-PROPORTIONAL PHARMACOKINETICS OF A NEW 5-LIPOXYGENASE INHIBITOR,ABT-761, IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 19(3), 1998, pp. 159-162

Authors: WONG SL DRAJESK J CHANG M LANNI C WITT G HANSEN R AWNI WM

Citation: Sl. Wong et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE ORAL DOSES OF A NOVEL 5-LIPOXYGENASE INHIBITOR (ABT-761) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 324-331

Authors: KEARNS GL WONG SL JOHNSON K DOWLING P KEMP JP DRAJESK J CHANG M DUBE L AWNI WM

Citation: Gl. Kearns et al., PHARMACOKINETICS OF A NOVEL 5-LIPOXYGENASE INHIBITOR (ABT-761) IN PEDIATRIC-PATIENTS WITH ASTHMA, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 80-80

Authors: AWNI WM WONG S CHU SY PATTERSON K HANSEN R MACHINIST JM DRAJESK J KEANE WF HALSTENSON CE

Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT, Journal of clinical pharmacology, 37(5), 1997, pp. 395-404

Authors: AWNI WM WONG S CHU SY PATTERSON K HANSEN R MACHINIST JM DRAJESK J KEANE WF HALSTENSON CE

Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 90-90